Related Experiment Video
Updated: Mar 25, 2026

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
5.1K
Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset
Josef Finsterer1, Sinda Zarrouk-Mahjoub2
1Department of Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria;
Sultan Qaboos University Medical Journal
|February 25, 2016
Summary
Mitochondrial disorders (MID) can initially mimic amyotrophic lateral sclerosis (ALS). Early diagnosis is crucial as MIDs progress to multi-organ dysfunction, potentially affecting the bulbar region.
Area of Science:
- Neurology
- Mitochondrial Biology
- Neurodegenerative Diseases
Background:
- Amyotrophic lateral sclerosis (ALS) and mitochondrial disorders (MID) share overlapping symptoms.
- Mitochondrial multiple organ dysfunction syndrome (MIMODS) can complicate diagnosis, especially in mild cases.
- Accurate differentiation is vital for appropriate patient management.
Purpose of the Study:
- To highlight the diagnostic challenges in differentiating MID from ALS.
- To present a case study illustrating the mimicry of ALS by MID.
- To emphasize the importance of considering MIDs in progressive neurological conditions.
Main Methods:
- Case report of a 48-year-old male with progressive neurological symptoms.
- Electrophysiological investigations initially suggesting ALS.
- Muscle biopsy revealing morphological features of MID and a combined complex-II/III defect.
- Longitudinal nerve conduction studies over a decade.
Main Results:
- The patient initially diagnosed with ALS showed features mimicking the disease.
- Muscle biopsy confirmed a mitochondrial disorder with a specific enzyme defect (complex II/III).
- The condition evolved from a seemingly isolated neurological issue to multi-organ involvement.
- Bulbar involvement was observed, a feature sometimes seen in both ALS and specific MIDs.
Conclusions:
- Mitochondrial disorders can present as amyotrophic lateral sclerosis, particularly in early stages.
- Long-term observation and specific diagnostic tests like muscle biopsy are essential for correct diagnosis.
- Combined complex II/III defects may manifest with bulbar symptoms, further complicating the differential diagnosis with ALS.
Related Concept Videos
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Cross-bridge Cycle
124.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
124.6K
Disorders of the Skeletal Muscle
2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Amyloid Fibrils
12.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Myasthenia Gravis: Diagnostic Tests
3.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K

